pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB
ASSEMBLY BIOSCIENCES
ASSEMBLY BIOSCIENCES, INC.
Assembly Biosciences is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker ASMB. Primary therapeutic focus areas include Chronic Hepatitis B, Recurrent Genital Herpes Simplex
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
- Founded
- 2014
- Employees
- 99
- Programs
- 15
- Drugs
- 10
- Patents
- 14
ABI-4334-102
Phase 1 · other · chronic hepatitis B virus infection (cHBV)
ABI-4334-102 for chronic hepatitis B virus infection (cHBV) is a Phase 1 program (other) at ASSEMBLY BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).
Internal code ABI-4334-102
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ASSEMBLY BIOSCIENCES, INC.
- Phase
- Phase 1
- Modality
- other
- Indication
- chronic hepatitis B virus infection (cHBV)
- Status
- active
- Trials
- 1